Parenteral Nutrition Market Trends

  • Report ID: 2775
  • Published Date: Oct 18, 2024
  • Report Format: PDF, PPT

Parenteral Nutrition Market Trends

Growth Drivers

Growing Geriatric Population and Rising Prevalence of Chronic Illnesses to Drive the Market Growth

Poverty is a big factor leading to malnutrition in older people. Many old people suffer from various disabilities, functional impairments, or chronic diseases. The rise in the medication, healthcare, and utility costs leads them to cut back on their food budget and as a result, they are unable to shop for groceries or cook for themselves and so they compromise on their diet which leads them to malnutrition.

Additionally, growing incidences of chronic diseases such as cancer, Chron’s disease, and others, influence the usage of parenteral nutrition around the globe. According to WHO, the number of cancer-related deaths around the world is projected to increase by 45%[AS1]  between 2008 to 2030.  Thus, the increasing number of government initiatives and healthcare organizations to spread awareness on the importance of a balanced diet coupled with the rising cases of cancer-related problems and inflammatory bowel syndromes are some of the key factors expected to drive the growth of the global market during the forecast period.

Increasing Prevalence of Malnutrition and Premature Births Worldwide to Further Expand the Market

Malnutrition is one of the key drivers in the parenteral nutrition market. According to the UNICEF, the unbalanced nutritional intake in babies during their initial few days after the birth may lead to diminished cognitive capacity and stunted development. Thus, the rise in the occurrences of malnutrition among children especially in developing and some developed nations across the globe, coupled with the need to properly balance the diets with vitamins, minerals, amino acids, lipids, and others nutrients are some of the major factors expected to further drive the growth of the global market.

Furthermore, an increasing number of C-section deliveries, premature births, and severely undernourished mothers giving birth to weak children are other prominent factors that are projected to accelerate the growth of the market over the forecast period.

Challenges

Side Effects Associated with Parenteral Nutrition to Hinder the Market Growth

Various side effects are associated with the inappropriate usage of parenteral nutrition such as re-feeding syndrome, catheter infections, particulate contamination, and liver dysfunction to the patients undergoing the therapy. These factors are estimated to hamper the market growth. The long-term usage of parenteral nutrition therapy significantly increases the risk of liver diseases, infections, and metabolic complications in patients. These factors coupled with the increasing demand for enteral nutrition is predicted to decrease the growth of the global market during the forecast period.

Parenteral Nutrition Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.9%

Base Year Market Size (2023)

USD 7.04 billion

Forecast Year Market Size (2036)

USD 14.83 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2775
  • Published Date: Oct 18, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of parenteral nutrition is assessed at USD 7.37 billion.

Parenteral Nutrition Market size was over USD 7.04 billion in 2023 and is projected to reach USD 14.83 billion by 2036, growing at around 5.9% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to account for largest revenue share by 2036, due to increasing cases of chronic diseases such as cancer and diabetes in the region, growing approval of the U.S. FDA approved parenteral nutrition products coupled with increased R&D investment funding by leading companies.

The major players in the market are Baxter International Inc., SGD Pharma, Pfizer Inc., B. Braun Melsungen AG, Fresenius Kabi, Grifols, S.A., Sichuan Kelun Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Claris Lifesciences Ltd., Aculife, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample